![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » LimFlow’s Stent Graph System Receives CE Mark
LimFlow’s Stent Graph System Receives CE Mark
![](https://www.fdanews.com/ext/resources/test/Drug-Images4/IVMachine.gif?t=1479252769&width=430)
November 15, 2016
LimFlow has received the CE Mark for its LimFlow Graph Stent System designed to increase blood flow to the lower limbs in patients at risk of limb amputation due to ischemia.
The LimFlow Stent Graft System consists of four main components: an arterial ultrasound catheter with needle, a venous ultrasound catheter, a covered nitinol stent in a delivery system and an ultrasound system.
This device is used to bypass diseased arteries and divert blood flow into the tibial vein in order to increase blood flow to the entire ischemic foot. — Cynthia Jessup
Upcoming Events
-
21Oct